February 1, 2017

Thermo Fisher Scientific: safely reduce antibiotic exposure

Antibiotics are a limited resource. At the current pace of injudicious use, all antibiotics will soon become ineffective. Panaxea together […]
August 17, 2016

Panaxea joins Flanders Innovation & Entrepreneurship

We’re proud to announce that Panaxea is now a certified service provider for the Flemish government under the SME grants […]
June 3, 2015

Articulating the value of diagnostics

Diagnostics face difficulties in current market conditions to obtain reimbursement and to enter the market efficiently. This white paper highlights […]
May 19, 2015

Generic decision model for diagnostic tests

To give (potential) clients a preliminary insight in the cost-effectiveness of their diagnostic test, we developed an online generic decision […]
March 31, 2015


Building upon our expertise and experience, Panaxea can organize or contribute to courses, seminars and workshops on a wide range […]
February 25, 2015

Systematic literature review

For a medical device company developing blood glucose meters, we performed a systematic literature review on self-monitoring of blood glucose […]
February 25, 2015

Market access and reimbursement report

A medical device company has developed a new technology that could improve the visualization and treatment of the affected heart […]
February 25, 2015

Cost-effectiveness and budget impact model for a diagnostic test

Allergic Rhinitis (AR) is a condition where an inflammatory reaction of the immune system is caused by specific allergens. Respiratory […]
January 22, 2014

Health economic modeling

For a global health company we evaluated the expected incremental cost-effectiveness of one of their products. The cost-effectiveness outcome was […]